FIRST RESULTS OF THE DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) Article Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I., Andrianova E., Baranovskiy P. EPMA Journal. BioMed Central Ltd.. Vol. 7. 2016.
DOUBLE-BLIND RANDOMIZED PLACEBOCONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION Article Ashrafian L., Sukhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E. EPMA Journal. BioMed Central Ltd.. Vol. 6. 2015.
DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION Article Ashrafian L., Suhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E. EPMA Journal. BioMed Central Ltd.. Vol. Vol625. 2015.
SAFETY AND TOLERABILITY OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) Article Paltsev M., Kiselev V., Muyzhnek E., Drukh V., Kuznetsov I., Pchelintseva O. EPMA Journal. BioMed Central Ltd.. Vol. 5. 2014.
COMPARATIVE PRECLINICAL PHARMACOKINETICS STUDY OF 3,3′-DIINDOLYLMETHANE FORMULATIONS: IS PERSONALIZED TREATMENT AND TARGETED CHEMOPREVENTION IN THE HORIZON? Article Paltsev Mikhail, Kiselev Vsevolod, Muyzhnek Ekaterina, Drukh Vadim, Kuznetsov Igor, Pchelintseva Olga EPMA Journal. BioMed Central Ltd.. Vol. 4. 2013. P. 1-8